Q3 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | Berkshire Grey Inc | $0 | – | -14,154,207 | – | -23.73% | – |
Q2 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IDYA | New | IDEAYA Biosciences Inc | $62,526,756 | – | 2,660,713 | – | 74.33% | – |
| New | Berkshire Grey Inc | $19,957,432 | – | 14,154,207 | – | 23.73% | – | |
| New | MONEYLION INCcl a | $1,632,856 | – | 135,958 | – | 1.94% | – |
Q4 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ITRM | Exit | Iterum Therapeutics plc | $0 | – | 0 | – | 0.00% | – |
| Exit | Berkshire Grey Inc | $0 | – | -14,154,207 | – | -37.74% | – | |
| IDYA | Exit | IDEAYA Biosciences Inc | $0 | – | -2,660,713 | – | -62.26% | – |
Q3 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | Berkshire Grey Inc | $24,062,000 | +16.0% | 14,154,207 | -1.0% | 37.74% | +5.2% | |
| ITRM | Sell | Iterum Therapeutics plc | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| ASTR | Exit | Astra Space Inc | $0 | – | 0 | – | 0.00% | – |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IDYA | New | IDEAYA Biosciences Inc | $36,718,000 | – | 2,660,713 | – | 63.52% | – |
| New | Berkshire Grey Inc | $20,739,000 | – | 14,302,523 | – | 35.88% | – | |
| ITRM | New | Iterum Therapeutics plc | $346,000 | – | 1,733,170 | – | 0.60% | – |
| ASTR | New | Astra Space Inc | $0 | – | 0 | – | 0.00% | – |
Q4 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ITRM | Exit | Iterum Therapeutics plc | $0 | – | -1,733,170 | – | -0.28% | – |
| NXTC | Exit | NextCure Inc | $0 | – | -321,647 | – | -0.62% | – |
| IDYA | Exit | IDEAYA Biosciences Inc | $0 | – | -2,660,713 | – | -19.31% | – |
| Exit | Berkshire Grey Inc | $0 | – | -14,302,523 | – | -28.62% | – | |
| ASTR | Exit | Astra Space Inc | $0 | – | -20,689,668 | – | -51.18% | – |
Q3 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASTR | New | Astra Space Inc | $179,793,000 | – | 20,689,668 | – | 51.18% | – |
| New | Berkshire Grey Inc | $100,547,000 | – | 14,302,523 | – | 28.62% | – | |
| NXTC | Sell | NextCure Inc | $2,168,000 | -67.8% | 321,647 | -61.6% | 0.62% | -93.9% |
Q2 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IDYA | New | IDEAYA Biosciences Inc | $55,848,000 | – | 2,660,713 | – | 83.88% | – |
| NXTC | New | NextCure Inc | $6,733,000 | – | 838,442 | – | 10.11% | – |
| ITRM | New | Iterum Therapeutics plc | $4,003,000 | – | 1,733,170 | – | 6.01% | – |
Q4 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ITRM | Exit | Iterum Therapeutics plc | $0 | – | -1,733,170 | – | -3.62% | – |
| NXTC | Exit | NextCure Inc | $0 | – | -1,711,513 | – | -29.94% | – |
| IDYA | Exit | IDEAYA Biosciences Inc | $0 | – | -2,660,713 | – | -66.44% | – |
Q3 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IDYA | Sell | IDEAYA Biosciences Inc | $33,418,000 | -55.8% | 2,660,713 | -50.0% | 66.44% | +46.5% |
| NXTC | Sell | NextCure Inc | $15,061,000 | -82.7% | 1,711,513 | -57.8% | 29.94% | -42.6% |
| ITRM | Sell | Iterum Therapeutics plc | $1,820,000 | -55.9% | 1,733,170 | -50.0% | 3.62% | +46.2% |
Q2 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NXTC | New | NextCure Inc | $86,980,000 | – | 4,056,884 | – | 52.17% | – |
| IDYA | New | IDEAYA Biosciences Inc | $75,618,000 | – | 5,321,426 | – | 45.36% | – |
| ITRM | New | Iterum Therapeutics plc | $4,124,000 | – | 3,466,340 | – | 2.47% | – |